David Altshuler Vertex Pharmaceuticals Inc (VRTX) insider trading activity

David Altshuler is EVP, Chief Scientific Officer of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 23,281 shares of VRTX, which is worth approximately $11.4 Million. The most recent transaction as insider was on Feb 10, 2022, when has been sold 3,518 shares (Common Stock) at a price of $237.74 per share, resulting in proceeds of $836,369. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.3K

9.81% 3M change

9.81% 12M change

Total Value Held $11.4 Million

DAVID ALTSHULER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 10 2022	SELL Payment of exercise price or tax liability	$836,369 $237.74 p/Share	3,518 Reduced 5.35%	62,179 Common Stock
Feb 02 2022	SELL Open market or private sale	$1,170,033 $251.08 p/Share	4,660 Reduced 6.62%	65,697 Common Stock
Feb 02 2022	BUY Exercise of conversion of derivative security	$403,183 $86.52 p/Share	4,660 Added 6.21%	70,357 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	32,108 Added 32.83%	65,697 Common Stock
Nov 15 2021	SELL Open market or private sale	$6,363 $187.15 p/Share	34 Reduced 0.1%	33,589 Common Stock
May 17 2021	SELL Open market or private sale	$17,084 $216.25 p/Share	79 Reduced 0.23%	33,589 Common Stock
Feb 25 2021	SELL Open market or private sale	$647,356 $213.79 p/Share	3,028 Reduced 8.27%	33,589 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$525,649 $217.57 p/Share	2,416 Reduced 6.19%	36,617 Common Stock
Feb 18 2021	SELL Open market or private sale	$1,658,509 $211.95 p/Share	7,825 Reduced 16.7%	39,033 Common Stock
Feb 17 2021	SELL Payment of exercise price or tax liability	$1,321,320 $211.75 p/Share	6,240 Reduced 11.75%	46,858 Common Stock
Feb 11 2021	SELL Open market or private sale	$1,114,924 $211.04 p/Share	5,283 Reduced 9.05%	53,098 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$636,912 $214.16 p/Share	2,974 Reduced 4.85%	58,381 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	32,453 Added 34.6%	61,355 Common Stock
Nov 16 2020	SELL Open market or private sale	$8,491 $223.45 p/Share	38 Reduced 0.13%	28,902 Common Stock

David Altshuler

EVP, Chief Scientific Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX

Account